A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup

Stopped early

Conditions studied: Osteoarthritis, Arthritis, Avascular Necrosis, Fracture of the Femoral Neck or Head, Congenital Hip Dysplasia

In brief

This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.

Key facts

Study ID

NCT02196818

Run by

Medacta International SA

People needed

200

Starts

2013-03-01

Expected to finish

2022-04-01

Last updated by the study team

2023-03-22

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
• Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
• Patients must be willing to comply with the pre and post-operative evaluation schedule.

You may not qualify if…

• Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.

Where it is running

• Vail Orthopedics, P.C. — Denver, Colorado, United States
• Saint Alphonsus Regional Medical Center — Boise, Idaho, United States
• Illinois Bone & Joint Institute, LLC — Libertyville, Illinois, United States
• Jordan Valley Medical Center — West Jordan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.